Treatment effectiveness can have different meanings to patients,” a physician assistant said when discussing therapy for high ...
Patients with breast cancer who are of childbearing age may face issues that are accentuated by their age, an expert ...
Extensive-stage (stage IV) SCLC, on the other hand, is a disease that has spread outside the bounds of 1 radiation field, and ...
A poll of experts revealed that few are utilizing talquetamab for patients with pretreated relapsed/refractory myeloma.
After a patient with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer experiences disease progression ...
Providers should consider lifestyle preferences and other conditions/comorbidities before deciding between bispecific antibodies or CAR T-cell therapy in myeloma. Lifestyle preferences and baseline ...
The FDA approved zolbetuximab-clzb (Vuloy) plus fluoropyrimidine- and platinum-containing chemotherapy for the treatment of patients with locally advanced unresectable or metastatic HER2-negative ...
Inavolisib plus palbociclib and fulvestrant was approved for the treatment of PIK3CA-mutant, HR-positive, HER2-negative locally advanced or metastatic breast cancer. The FDA approved inavolisib ...
Nurses, Talk AEs, Interstitial Lung Disease, Before Treating With T-DXd ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback